Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of randomised clinical trials impacted by COVID-19 and force majeure events.|
|Full bibliographic reference||Leung TH, Ho JC, El Helali A, Vokes EE, Wang X, Pang H. New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach. Ann Transl Med.2023;11(1):2.|
|Study design||Clinical trials, Experimental studies|
|Applies to the whole report or to individual sections of the report?||Abstract, Harms/adverse effects/safety data, Intervention (exposure), Narrative sections (discussion etc.), Procedure/Method, Results, Statistical methods and analyses, Study characteristics (participants etc.)|
|Record last updated on||May 16, 2023|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.